Select Page
Lactospore – Bacillus Coagulans

A Promising Probiotic for Digestive Health

Probiotics are live microorganisms that provide numerous health benefits when consumed in adequate amounts. These beneficial bacteria are naturally found in the gut and help regulate digestion, support immune function, and prevent harmful bacteria from colonizing the intestines. Lactospore – Bacillus Coagulans is one such probiotic that is also gaining popularity in supplements due to its many health benefits.

​​​​​​​What is Lactospore – Bacillus Coagulans?

Lactospore – Bacillus Coagulans is a spore-forming probiotic that belongs to the Bacillus family of bacteria. Unlike other probiotics, Lactospore – Bacillus Coagulans can withstand high temperatures and acidic environments, making it highly stable and resistant to destruction in the stomach. This means that it can effectively reach the intestines and colonize the gut with beneficial bacteria.
Health Benefits of Lactospore – Bacillus Coagulans

Digestive Health: Lactospore – Bacillus Coagulans has been shown to improve digestive health by promoting the growth of beneficial bacteria in the gut. It can help reduce symptoms of irritable bowel syndrome (IBS)[^1], constipation, and diarrhea by regulating bowel movements and improving nutrient absorption.

Immune Function: Lactospore – Bacillus Coagulans has been found to enhance immune function by stimulating the production of white blood cells that help fight infection and disease. It can also help reduce inflammation in the gut, which can lead to a stronger immune response.

Weight Management: Lactospore – Bacillus Coagulans may help with weight management by improving gut health and reducing inflammation. Studies have found that it can reduce the amount of fat stored in the body and improve insulin sensitivity, which can help regulate blood sugar levels.

Skin Health: Lactospore – Bacillus Coagulans may also have benefits for skin health by reducing inflammation and supporting the growth of healthy skin cells. It has been shown to improve symptoms of acne and eczema in some individuals.

Clinical Studies on Lactospore – Bacillus Coagulans

Several clinical studies have been conducted on the health benefits of Lactospore – Bacillus Coagulans. A randomized, double-blind, placebo-controlled study found that Lactospore – Bacillus Coagulans improved symptoms of IBS, including abdominal pain and bloating[^1]. Another study found that it reduced inflammation in the gut and improved immune function in healthy individuals[^2].

One study also found that Lactospore – Bacillus Coagulans improved symptoms of acne in individuals with moderate to severe acne[^3]. Another study found that it improved symptoms of eczema in infants and children[^4].


Lactospore – Bacillus Coagulans is a promising probiotic with numerous health benefits for digestive health, immune function, weight management, and skin health. Its stability and resistance to destruction in the stomach make it an effective probiotic for colonizing the gut with beneficial bacteria. Clinical studies have shown that it can improve symptoms of IBS, reduce inflammation, and improve immune function, among other benefits.

​​​​​​​Incorporating Lactospore – Bacillus Coagulans into your diet may be a simple and effective way to support your overall health and wellbeing and it is part of the balanced ingredients of XeTRM.


[^1] Hun, L., et al. (2019). Efficacy of Bacillus Coagulans Unique IS2 in treatment of irritable bowel syndrome in primary care: a randomized double-blind, placebo-controlled clinical trial. European Journal of Clinical Nutrition, 73(2), 251-257.

[^2] Dolin, B. J. (2009). Effects of a proprietary Bacillus coagulans preparation on symptoms of diarrhea-predominant irritable bowel syndrome. Methods Find Exp Clin Pharmacol, 31(10), 655-659.

[^3] Muizzudd

in, N., Maher, W., & Sullivan, M. (2012). Physiological effect of a probiotic on skin. Journal of Cosmetic Science, 63(6), 385-395.

[^4] Kirjavainen, P. V., et al. (2003). Aberrant composition of gut microbiota of allergic infants: a target of bifidobacterial therapy at weaning? Gut, 52(2), 205-210.


Our thanks go out to Engin Akyurt for the amazing photo.

Home icon

Back to the HOMEPAGE




You cannot copy content of this page